Trial of vaccine in HIV patients from 6 years old to older

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-011564-11

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the immune responses 1 month after 3 doses of 13vPnC compared to 1 month after 2 doses of 13vPnC as measured by fold rises of serotype-specific immunoglobulin G (IgG) geometric mean antibody concentrations (GMC) in individuals ≥6 years of age.


Critère d'inclusion

  • Pneumococcal infection in HIV infected subjects

Liens